Danijela Heide

German Cancer Research Center — Germany

Medicine · Health Sciences

20h-index3.4kcitations53works9.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(12), MicroRNA in disease regulation(6), Hepatitis B Virus Studies(5), Cancer-related molecular mechanisms research(5), Hepatitis C virus research(4)

Publications53 total

Activated ATF6α is a hepatic tumour driver restricting immunosurveillance
Nature·2026Open Access
ER Stress Sensor Atf6α is Decisive for T cell Tumor Immunosurveillance in MASH-HCC
Zeitschrift für Gastroenterologie·2026
Targeting peroxiredoxin 2 prevents hepatocarcinogenesis in metabolic liver disease
Free Radical Biology and Medicine·2025
Targeting peroxiredoxin 2 prevents hepatocarcinogenesis in metabolic liver disease models
Journal of Clinical Investigation·2025· 1 citedOpen Access
Age-Related Gliosis Promotes Central Nervous System Lymphoma through CCL19-Mediated Tumor Cell Retention
Cancer Cell·2025· 3 cited
FRI-066 The tumor suppressor miR-122 regulates liver cancer stem cells immune evasion and proliferation through CD24
Journal of Hepatology·2025
FRI-064 MicroRNA-122 functions as a rheostat regulating liver tolerance, inflammation and fibrosis
Journal of Hepatology·2025
Abstract 2369: Targeting peroxiredoxin 2 prevents hepatocellular carcinoma development in metabolic liver disease
Cancer Research·2025
Active repression of cell fate plasticity by PROX1 safeguards hepatocyte identity and prevents liver tumorigenesis
Nature Genetics·2025· 10 citedOpen Access
Antibiotic-mediated microbiota depletion limits IgA-related fibrogenesis in metabolic dysfunction-associated steatohepatitis
Zeitschrift für Gastroenterologie·2025
Active repression of cell fate plasticity by PROX1 safeguards hepatocyte identity and prevents liver tumourigenesis
2024· 1 citedOpen Access
Ribosomal S6 kinase 1 regulates inflammaging via the senescence secretome
Nature Aging·2024· 21 citedOpen Access
Targeting the liver clock improves fibrosis by restoring TGF-β signaling
Journal of Hepatology·2024· 35 citedOpen Access
Lymphotoxin beta‐activated <scp>LTBR/NIK/RELB</scp> axis drives proliferation in cholangiocarcinoma
Liver International·2024· 7 citedOpen Access
OS-103 Antibiotic-mediated microbiota depletion limits IgA-related fibrogenesis in metabolic dysfunction-associated steatohepatitis
Journal of Hepatology·2024
A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPARα and PCK1
Cell Metabolism·2024· 75 citedOpen Access
Aged intestinal stem cells propagate cell-intrinsic sources of inflammaging in mice
Developmental Cell·2023· 39 citedOpen Access
Corrigendum to “Comparison of HAV and HCV infections in vivo and in vitro reveals distinct patterns of innate immune evasion and activation” [J Hepatol (2023) 645–656]
Journal of Hepatology·2023Open Access
Beneficial effects of intermittent fasting in NASH and subsequent HCC development are executed by concerted PPARα and PCK1 action in hepatocytes
2023· 2 citedOpen Access
Ribosomal S6 kinase 1 regulates ‘inflammaging’ via the senescence secretome
2023· 1 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Mathias Heikenwälder(45), Jenny Hetzer(17), Émilie Crouchet(9), Frank Jühling(9), Marine A. Oudot(9), Sarah Durand(9), Clara Ponsolles(9), Patrick Pessaux(9), Emanuele Felli(9), Catherine Schuster(9), Thomas F. Baumert(9), Suchira Gallage(8), Sandra Prokosch(8), Yujin Hoshida(8), Dominik Pfister(7), Naoto Fujiwara(7), Hussein El Saghire(7), Nathalie Pochet(7), Adrian T. Billeter(6), Percy A. Knolle(6)